Due to Opioid Smuggling, the FDA Suspends Aveo Pharmaceuticals’ Accreditation
The Food and Drugs Authority (FDA) has suspended the Good Manufacturing Practices (GMP) certification of Aveo Pharmaceuticals, an Indian drug manufacturer, following revelations of its involvement in the illegal distribution of opioid-based medications to West Africa